[Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
D000262:Adenylyl Cyclases / Q000378:metabolism; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D002375:Catalepsy / Q000139:chemically induced; D002415:Cats; D003214:Conditioning, Classical / Q000187:drug effects; D004195:Disease Models, Animal; D004285:Dogs; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D006801:Humans; D066298:In Vitro Techniques; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism; D014839:Vomiting / Q000188:drug therapy
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D000661:Amphetamine; D000262:Adenylyl Cyclases; D001058:Apomorphine; D004298:Dopamine
Zur Wirkung von Psychopharmaka auf den zentralen Dopamin-Stoffwechsel (Beispiel: Neuroleptika).